About
Werewolf Therapeutics Inc (NASDAQ:HOWL) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 27 2026
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Feb 24 2026
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
Dec 18 2025
Werewolf Therapeutics Announces Pipeline and Business Updates
Nov 7 2025
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Nov 4 2025
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Financials
Revenue
$0
Market Cap
$49.08 M
EPS
-1.33
Translate